Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Werewolf Therapeutics, Inc. (HOWL) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/10/2023 4 RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Bought 1,853,000 shares @ $2.21, valued at $4.1M
01/09/2023 4 HICKLIN DANIEL J (See Remarks) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Granted 295,500 options to buy @ $2.05, valued at $605.8k
01/09/2023 4 Lubman Ellen (Chief Business Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Granted 86,200 options to buy @ $2.05, valued at $176.7k
01/09/2023 4 Seidel-Dugan Cynthia (Chief Scientific Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Granted 115,900 options to buy @ $2.05, valued at $237.6k
01/09/2023 4 Karunatilake Chulani (Chief Technology Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Granted 103,600 options to buy @ $2.05, valued at $212.4k
01/09/2023 4 Trost Timothy W. (CFO) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Granted 102,800 options to buy @ $2.05, valued at $210.7k
01/09/2023 4 Leonard Reid (COO) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Granted 93,600 options to buy @ $2.05, valued at $191.9k
01/09/2023 4 Isaacs Randi (Chief Medical Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Granted 103,300 options to buy @ $2.05, valued at $211.8k
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2022 4 DiRocco Derek (Director) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Granted 11,600 options to buy @ $3.43, valued at $39.8k
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2022 4 Karunatilake Chulani (Chief Technology Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Granted 136,000 options to buy @ $3.43, valued at $466.5k
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2022 4 Lazarus Alon (Director) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Granted 11,600 options to buy @ $3.43, valued at $39.8k
06/03/2022 4 Chatterjee Meeta (Director) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Granted 7,733 options to buy @ $3.43, valued at $26.5k
01/18/2022 4 Isaacs Randi (Chief Medical Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Granted 79,516 options to buy @ $11.55, valued at $918.4k
01/18/2022 4 Leonard Reid (COO) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Granted 70,967 options to buy @ $11.55, valued at $819.7k
01/18/2022 4 Trost Timothy W. (CFO) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Granted 65,960 options to buy @ $11.55, valued at $761.8k
01/18/2022 4 HICKLIN DANIEL J (See Remarks) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Granted 215,888 options to buy @ $11.55, valued at $2.5M
01/18/2022 4 Lubman Ellen (Chief Business Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Granted 51,088 options to buy @ $11.55, valued at $590.1k
01/18/2022 4 Karunatilake Chulani (Chief Technology Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Granted 34,258 options to buy @ $11.55, valued at $395.7k
01/14/2022 4 Seidel-Dugan Cynthia (Chief Scientific Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Granted 79,516 options to buy @ $11.55, valued at $918.4k
Exercised 24,199 options to buy @ $1.56, valued at $37.8k
Exercised 15,532 options to buy @ $4.77, valued at $74.1k
01/04/2022 4 Leonard Reid (COO) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Exercised 14,102 options to buy @ $1.56, valued at $22k
12/17/2021 4 Leonard Reid (COO) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Sold 2,865 shares @ $13.3875, valued at $38.4k
Sold 135 shares @ $13.9736, valued at $1.9k
11/01/2021 4 Chatterjee Meeta (Director) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Granted 23,200 options to buy @ $15.97, valued at $370.5k
07/02/2021 4 Karunatilake Chulani (Chief Technology Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns: Granted 272,000 options to buy @ $19.23, valued at $5.2M
06/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/28/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy